Back to search

United States· US:71872-7202_fb465fb4-2feb-6ef9-e053-6394a90a655a

rocuronium bromide

A rocuronium bromide product containing rocuronium bromide, registered in United States by Medical Purchasing Solutions, LLC. The same ATC class is registered in 13 of our 19 countries.

In shortageATC M03AC09Orange BookUS label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedrocuronium bromideATCM03AC09REGISTER NO.US:71872-7202_fb465fb…PACKS LISTED1CHECKEDJune 3, 2026

Where it is registered

Rocuronium bromide is registered in 13 of 19 countries.

Countries holding a registration under ATC M03AC09 (rocuronium bromide), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 8 of them publish a price we can compare per daily dose

Rocuronium bromide · ATC M03AC09

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
rocuronium bromide
Manufacturer
Medical Purchasing Solutions, LLC
Country
United States (US)
ATC code
M03AC09
ATC class
Rocuronium bromide
Defined daily dose
42 mg, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
June 3, 2026

Packs & prices · 1

  • ndc11
    7187272021
    1 VIAL in 1 BAG (71872-7202-1) / 5 mL in 1 VIAL

Regulatory notes

UNII (FDA substance ID)
I65MW4OFHZ
ROCURONIUM BROMIDE
RxCUI 32521
Orange Book
A091458
APAP
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Rocuronium Bromide Injection

Interactions

109 interactions on record for rocuronium bromide.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Rocuronium bromide · interactions on record

109 records

  • 12 severe
  • 59 moderate
  • 4 minor
  • 34 info

Most severe, free to view

  • NeomycinA07AA01severe
  • StreptomycinA07AA04severe
  • Polymyxin BA07AA05severe
  • ParomomycinA07AA06severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Rocuronium bromide in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rocuronium bromide products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Rocuronium Kalceks, Rocuroniumbromid Accord
  • Belgium · Esmeron, Rocuronium B. Braun
  • Bulgaria · Рокурониев Ромфарм, Рокурониум Б. Браун
  • Cyprus · Esmeron, Rocudem
  • Czechia · Esmeron, Rocuronium B. Braun
  • Germany · Rocuronium Aguettant, Rocuronium Inresa
  • Denmark · Rocuronium Bromide Accord, Rocuronium Bromide Aguettant
  • Estonia · Rocuronium Bromide Fresenius Kabi, Rocuronium Bromide Kalceks
  • Spain · Rocuronio Aguettant, Rocuronio B. Braun
  • Finland · Rocuronium B. Braun, Rocuronium Bromide Accord
  • France · Rocuronium, Rocuronium Aguettant
  • United Kingdom (Northern Ireland) · Esmeron, Rocuronium B. Braun Melsungen
  • Greece · Esmeron, Rocudem
  • Croatia · Rokuronijev Bromid B. Braun, Rokuronijev Bromid Fresenius Kabi
  • Hungary · Rocuronium Bromide Hameln, Rocuronium Bromide Noridem
  • Ireland · Esmeron, Rocuronium
  • Iceland · Rocuronium Aguettant
  • Italy · Esmeron, Rocuronio Accord
  • Lithuania · Rocuronium Bromide Kalceks, Roqurum
  • Luxembourg · Esmeron, Rocuronium Bromide Aguettant
  • Latvia · Rocuronium Bromide Kalceks
  • Malta · Rocuronium Bromide As Kalceks, Rocuronium Bromide Ibigen
  • Netherlands · Esmeron, Rocuroniumbromide Accord
  • Norway · Rocuronium Bromide Accord, Rocuronium Bromide Aguettant
  • Poland · Rocuronium, Rocuronium Bromide Hameln
  • Portugal · Brometo De Rocurónio Accord, Brometo De Rocurónio Aguettant
  • Romania · Esmeron, Rocuronium Aguettant
  • Sweden · Rocuronium Accord, Rocuronium B. Braun
  • Slovenia · Rokuronijev Bromid B. Braun, Rokuronijev Bromid Hameln
  • Slovakia · Rocuronium B. Braun, Rocuronium Bromide Hameln

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d1d85099-277c-44b3-88ab-df2f92e0ab19
GET /v1/drugs/d1d85099-277c-44b3-88ab-df2f92e0ab19?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "I65MW4OFHZ",
    "rxcui": "32521",
    "inchikey": "OYTJKRAYGYRUJK-FMCCZJBLSA-M",
    "display_name": "ROCURONIUM BROMIDE",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "INTRAVENOUS",
  "spl_meta": {
    "d3a172a5-01ab-47d8-92ac-a8539b1d4dc4": {
      "match": "brand_token",
      "title": "ROCURONIUM BROMIDE INJECTION [HIKMA PHARMACEUTICALS USA INC.]",
      "spl_version": "12",
      "published_date": "2026-05-21"
    }
  },
  "productid": "71872-7202_fb465fb4-2feb-6ef9-e053-6394a90a655a",
  "productndc": "71872-7202",
  "dosage_form": "INJECTION, SOLUTION",
  "orange_book": {
    "appl_no": "091458",
    "products": [
      {
        "rs": false,
        "rld": false,
        "te_code": "AP",
        "strength": "50MG/5ML (10MG/ML)",
        "product_no": "001",
        "approval_date": "Jul 28, 2010"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AP",
        "strength": "100MG/10ML (10MG/ML)",
        "product_no": "002",
        "approval_date": "Jul 28, 2010"
      }
    ],
    "appl_type": "A"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "ROCURONIUM BROMIDE",
  "shortage_reason": "Rocuronium Bromide Injection",
  "shortage_status": "current",
  "proprietary_name": "rocuronium bromide",
  "active_ingred_unit": "mg/mL",
  "application_number": "ANDA091458",
  "marketing_category": "ANDA",
  "nonproprietary_name": "rocuronium bromide",
  "start_marketing_date": "20111220",
  "active_numerator_strength": "10"
}

See everything about rocuronium bromide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.